標(biāo)題: Titlebook: mTOR Inhibition for Cancer Therapy: Past, Present and Future; Monica Mita,Alain Mita,Eric K. Rowinsky Book 2016 Springer-Verlag France 201 [打印本頁(yè)] 作者: FLAW 時(shí)間: 2025-3-21 19:18
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future影響因子(影響力)
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future影響因子(影響力)學(xué)科排名
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future網(wǎng)絡(luò)公開(kāi)度
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future被引頻次
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future被引頻次學(xué)科排名
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future年度引用
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future年度引用學(xué)科排名
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future讀者反饋
書目名稱mTOR Inhibition for Cancer Therapy: Past, Present and Future讀者反饋學(xué)科排名
作者: 彩色的蠟筆 時(shí)間: 2025-3-21 20:49 作者: expdient 時(shí)間: 2025-3-22 01:30 作者: MODE 時(shí)間: 2025-3-22 08:32
https://doi.org/10.1007/978-2-8178-0492-7Akt; cancer; mTOR; rapamycin; Molecular作者: Jingoism 時(shí)間: 2025-3-22 10:50 作者: FILTH 時(shí)間: 2025-3-22 13:50
Monica Mita,Alain Mita,Eric K. RowinskyFirst book on that topic.Input and perspectives by international leaders?.Preclinical and clinical data available on the subject have been integrated.A dedicated chapter on toxicity profile of mTOR in作者: Simulate 時(shí)間: 2025-3-22 19:37 作者: 鴕鳥(niǎo) 時(shí)間: 2025-3-23 01:05
mTOR Inhibition for Cancer Therapy: Past, Present and Future978-2-8178-0492-7作者: lobster 時(shí)間: 2025-3-23 01:51
Book 2016 already underway. Second-generation small-molecule inhibitors of the pathway have also shown promise in terms of their superior tolerability and efficacy and are undergoing extensive clinical evaluation, with an estimated 30+ compoundscurrently under evaluation. .作者: 奇怪 時(shí)間: 2025-3-23 06:28 作者: hidebound 時(shí)間: 2025-3-23 12:16
第4樓作者: 顛簸下上 時(shí)間: 2025-3-23 14:10
第4樓作者: Exhilarate 時(shí)間: 2025-3-23 19:51
5樓作者: gerontocracy 時(shí)間: 2025-3-24 02:12
5樓作者: MARS 時(shí)間: 2025-3-24 02:35
5樓作者: Radiation 時(shí)間: 2025-3-24 09:49
5樓作者: 偽善 時(shí)間: 2025-3-24 11:57
6樓作者: antiandrogen 時(shí)間: 2025-3-24 15:54
6樓作者: Mystic 時(shí)間: 2025-3-24 22:15
6樓作者: 搖曳的微光 時(shí)間: 2025-3-25 00:44
6樓作者: 斜 時(shí)間: 2025-3-25 04:44
7樓作者: ABHOR 時(shí)間: 2025-3-25 11:03
7樓作者: 一條卷發(fā) 時(shí)間: 2025-3-25 13:49
7樓作者: 周年紀(jì)念日 時(shí)間: 2025-3-25 17:23
7樓作者: 職業(yè) 時(shí)間: 2025-3-25 20:14
8樓作者: CURT 時(shí)間: 2025-3-26 03:34
8樓作者: 無(wú)所不知 時(shí)間: 2025-3-26 06:37
8樓作者: brachial-plexus 時(shí)間: 2025-3-26 12:09
8樓作者: Impugn 時(shí)間: 2025-3-26 16:40
9樓作者: GEN 時(shí)間: 2025-3-26 19:09
9樓作者: Coeval 時(shí)間: 2025-3-26 23:20
9樓作者: FLAX 時(shí)間: 2025-3-27 03:19
9樓作者: prediabetes 時(shí)間: 2025-3-27 07:29
10樓作者: 浸軟 時(shí)間: 2025-3-27 11:00
10樓作者: 眨眼 時(shí)間: 2025-3-27 17:12
10樓作者: 最后一個(gè) 時(shí)間: 2025-3-27 18:23
10樓
